Company Filing History:
Years Active: 2012-2015
Title: Innovations of Mats Peter Anderson
Introduction
Mats Peter Anderson is a notable inventor based in Kävlinge, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications. With a total of 2 patents to his name, Anderson's work is paving the way for advancements in medical treatments.
Latest Patents
Anderson's latest patents focus on mutants of interleukin-1 receptor antagonist. The invention provides an isolated polypeptide comprising a variant amino acid sequence of SEQ ID NO: 1, or a fusion or derivative of said polypeptide, or a fusion of a said derivative thereof. This polypeptide, fusion, or derivative retains a biological activity of wild type IL-IRa. In one embodiment, the isolated polypeptide, fusion, or derivative is or comprises a polypeptide variant of amino acid sequence SEQ ID NO: 1, which includes substitutions at one or more of the following amino acid mutations: Q29K, P38Y, P38R, L42W, D47N, E52R, H54R, E90Y, Q129L, Q129N, M136N, M136D, and Q149K. Additionally, the patents provide pharmaceutical compositions of the above polypeptide, fusion, or derivative, as well as their uses for treating diseases or conditions that can be addressed by agents inhibiting the function of IL-1 receptors.
Career Highlights
Mats Peter Anderson is currently associated with Alligator Bioscience AB, where he continues to innovate in the field of biotechnology. His work is characterized by a strong focus on developing therapeutic agents that can significantly impact patient care.
Collaborations
Anderson collaborates with esteemed colleagues such as Eva Maria Dahlén and Patrick Thomas Höjman. Their combined expertise contributes to the advancement of their research and the development of innovative solutions in biotechnology.
Conclusion
Mats Peter Anderson's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work on interleukin-1 receptor antagonists showcases the potential for innovative treatments in medicine.